Pan-Cancer Detection Through DNA Methylation Profiling Using Enzymatic Conversion Library Preparation with Targeted Sequencing
International Journal of Molecular Sciences · 2025
DOI: 10.3390/ijms262010165 ↗Kurz gefasst
Fachartikel in der Zeitschrift International Journal of Molecular Sciences, 2025. Verfasst von Alvida Qvick und 7 weiteren Autor:innen. Beteiligte Einrichtung: Clinical Research Center, Faculty of Medicine and Health, Örebro University, SE-701 85 Örebro, Sweden. Hauptthemen laut MEDLINE: DNA Methylation, Neoplasms. Die Arbeit wurde bisher 4-mal zitiert (Crossref) und nennt 57 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: Örebro County Research Committee, Lions Cancer Research Foundation, Swedish state - ALF-agreement.
Abstract (Originalsprache)
We investigated differences in circulating cell-free DNA (cfDNA) methylation between patients with cancer and those presenting with severe, nonspecific symptoms. Plasma cfDNA from 229 patients was analyzed, of whom 37 were diagnosed with a wide spectrum of cancer types within 12 months. Samples underwent enzymatic conversion, library preparation, and enrichment using the NEBNext workflow and Twist pan-cancer methylation panel, followed by sequencing. Methylation analysis was performed with nf-core/methylseq. Differentially methylated regions (DMRs) were identified with DMRichR. Machine learning with cross-validation was used to classify cancer and controls. The classifier was applied to an external validation set of 144 controls previously unseen by the model. Cancer samples showed higher overall CpG methylation than controls (1.82% vs. 1.34%, p < 0.001). A total of 162 DMRs were detected, 95.7% being hypermethylated in cancer. Machine learning identified 20 key DMRs for classification between cancer and controls. The final model achieved an AUC of 0.88 (83.8% sensitivity, 83.8% specificity), while mean cross-validation performance reached an AUC of 0.73 (57.1% sensitivity, 77.5% specificity). The specificity of the classifier on unseen control samples was 79.2%. Distinct methylation differences and DMR-based classification support cfDNA methylation as a robust biomarker for cancer detection in patients with confounding conditions.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Clinical Research Center, Faculty of Medicine and Health, Örebro University, SE-701 85 Örebro, Sweden.
- Department of Obstetrics and Gynecology, Faculty of Medicine and Health, Örebro University, SE-701 85 Örebro, Sweden.
- Department of Laboratory Medicine, Örebro University Hospital, SE-701 85 Örebro, Sweden.
- Department of Urology, Faculty of Medicine and Health, Örebro University, SE-701 85 Örebro, Sweden.
- School of Health Sciences, Örebro University, SE-701 85 Örebro, Sweden.
- ATMP Center, Skåne University Hospital, SE-222 42 Lund, Sweden.
ORCID-Profile: Alvida Qvick, Emma Adolfsson, Jessica Carlsson, Bianca Stenmark, Christina Karlsson, Gisela Helenius
Förderung
- Örebro County Research Committee
- Lions Cancer Research Foundation
- Swedish state - ALF-agreement
- Region Örebro Län
- Swedish state
Zitieren
APA
Qvick, A., Adolfsson, E., Tornéus, L., Lindqvist, C. M., Carlsson, J., Stenmark, B., Karlsson, C., & Helenius, G. (2025). Pan-Cancer Detection Through DNA Methylation Profiling Using Enzymatic Conversion Library Preparation with Targeted Sequencing. International Journal of Molecular Sciences. https://doi.org/10.3390/ijms262010165
Vancouver
Qvick A, Adolfsson E, Tornéus L, Lindqvist CM, Carlsson J, Stenmark B, et al. Pan-Cancer Detection Through DNA Methylation Profiling Using Enzymatic Conversion Library Preparation with Targeted Sequencing. International Journal of Molecular Sciences. 2025. doi:10.3390/ijms262010165
BibTeX
@article{Qvick2025,
author = {Qvick, Alvida and Adolfsson, Emma and Tornéus, Lina and Lindqvist, Carl Mårten and Carlsson, Jessica and Stenmark, Bianca and Karlsson, Christina and Helenius, Gisela},
title = {Pan-Cancer Detection Through DNA Methylation Profiling Using Enzymatic Conversion Library Preparation with Targeted Sequencing},
journal = {International Journal of Molecular Sciences},
year = {2025},
doi = {10.3390/ijms262010165}
}
EUVIMED